Awards and Honors for Fox Chase Research

By the time The Scientist completed its "Best Places to Work" series in August 2013, Fox Chase had been a top-ranking institution three years in a row.  Fox Chase Cancer Center rated 7th on the list of Top Ten Best Places to Work Academia 2013.

This builds on years of a top rating for Best Places for Post-Doctorates.

Read more at The Scientist.

Also see: 

Fox Chase's Postdoctoral Program is Ranked Third in the Country by The Scientist's 10th Annual Best Places to Work for Postdocs Survey
(Mar 29, 2012)
Fox Chase Listed Among the Top Places in the Nation for Postdocs
(Mar 1, 2011)

Research Award Highlights:

  • Igor A. Astsaturov, MD, PhD, has received news of an award from the National Institutes of Health—an R01 grant for approximately $2.2 million over five years to study “Synergistic Targeting of Cholesterol Metabolism and EGFR Signaling in Cancer.” The grant will be used to investigate the role of sterol metabolism in cancer signaling.
  • Siddharth Balachandran, PhD, received a nearly $500,000 grant over two years from the National Institutes of Health to study “Control of Interferon-Activated Necrosis by a Virus-Triggered FADD Checkpoint.” This study seeks to understand how secreted proteins, called interferons, induce the necrotic death of virus-infected cells.
  • Neil Johnson, PhD, received the Basser Innovation Award for $100,000 over one to two years through the external research grant program of the Basser Research Center for BRCA at Penn Medicine’s Abramson Cancer Center. The grant will help fund his work on cancers associated with the BRCA1 and BRCA2 gene mutations.
  • Dietmar J. Kappes, PhD, was notified of an award for approximately $2.2 million over five years in the form of an R01 grant from the National Institutes of Health to study “Dissecting the Role of ThPOK in Thymic Development and T Cell Differentiation.” This grant explores the role of the transcription factor ThPOK in controlling normal T cell development and function.

The Philadelphia Chromosome

The discovery of the Philadelphia Chromosome took place in 1959 under a Fox Chase Cancer Center microscope. Hundreds of drugs for cancer that target specific molecules are being developed from this start.


Irwin A. "Ernie" Rose, PhD

2004 Nobel Prize in Chemistry: Ibiquitin

Fox Chase scientist Irwin A. "Ernie" Rose, PhD, working with Avram Hershko, MD, PhD, and Aaron Ciechanover, PhD, both from the Technion-Israel Institute of Technology in Haifa, Israel, won the 2004 Prize for a series of epoch-making biochemical studies on the breakdown of proteins within cells. 


Baruch S. Blumberg, MD, PhD: Research

1976 Nobel Prize in Physiology or Medicine:
The Discovery of the Hepatitis B Virus

Dr. Blumberg receiving his Nobel, 1976The research, discoveries and vision of Nobel laureate Baruch S. Blumberg, MD, PhD, (1925-2011) have had a far-reaching impact on public health around the globe.

Dr. Blumberg was awarded the 1976 Nobel Prize in medicine for his 1967 discovery of the hepatitis B virus and he received many subsequent honors, including election to the National Academy of Sciences, the American Philosophical Society and the National Inventors Hall of Fame.


The Kyoto Prize

Cancer researcher Alfred G. Knudson Jr., MD, PhD, (pronounced ka-nud'-son) of Fox Chase Cancer Center was named winner of a prestigious Kyoto Prize for 2004. The Kyoto Prize is considered among the world's leading awards for lifetime achievement and is given to those who have "contributed significantly to mankind's betterment."


The Lasker Award

Albert Lasker Clinical Medical Research Award, 1998
Alfred Knudson, Jr., Peter Nowell, and Janet Rowley
For incisive studies in patient-oriented research that paved the way for identifying genetic alterations that cause cancer in humans and that allow for cancer diagnosis in patients at the molecular level.